What’s the Glue Holding EHR Migration and Conversion Projects Together?
August 14, 2015
Caristix is sponsoring a series of blogs posts on John Lynn’s Hospital EMR and EHR blog. You can read the latest post, What’s the Glue
Caristix is sponsoring a series of blogs posts on John Lynn’s Hospital EMR and EHR blog. You can read the latest post, What’s the Glue
Interoperability barriers and HIE business models In a previous post, we talked about the interoperability barriers facing HIEs (healthcare information exchanges). What are they? Primarily
The purpose of HL7 interface validation In the interface lifecycle, validation is critical. HL7 interface validation is about checking the interface you’ve developed: making sure
Over the past few weeks, we’ve reviewed multiple HL7 testing topics. So you know how critical it is to test interfaces during interface configuration, the
Tip 16 in the Interoperability Tip Series The past few tips have covered HL7 testing and test automation. This one covers what you should do
Tip 15 in the Interoperability Tip Series Once you’ve developed a test plan and test scenarios, you need to configure your interface in a test
Tip 14 in the Interoperability Tip Series In last week’s tip, we talked about capturing workflows. Here’s why. Before you can conduct any interface testing,
Testing and validation are important tasks, as we explained in the Interoperability Tip Series and the HL7 Survival Guide. Shouldn’t interfacing be easy by now?
Tip 13 in the Interoperability Tip Series Last week in Tip 12, we covered when, why, and what to test when you’re working with interfaces.
Tip 12 in the Interoperability Tip Series In tips from the past few weeks, we covered two requirements-related artifacts analysts must create: 1) profiles or
NORTH AMERICA: +1 (877)-872-0027
WORLD: 1-418-872-4000
EMAIL: info@caristix.com
ASIA-PACIFIC
DENIS CANTIN
T: +61418441388
denis.cantin@caristix.com
NORTH AMERICA & EUROPE
JEAN-LUC MORIN
T: 418 872-4000
jeanluc.morin@caristix.com
HL7® / FHIR® are a registered trademarks of Health Level Seven International. The use of this trademark does not constitute an endorsement by HL7.